Search Results for "Tensha Pharmaceuticals"
Original Source: Tensha Therapeutics
Tensha Therapeutics is developing small molecule bromodomain inhibitors, a new class of epigenetic modulators of gene expression, to treat cancer and other serious disorders. The companyâs programs are based on the discovery from the laboratory of Dr. James Bradner at Dana-Farber Cancer Institute of first-in-class, potent small molecule BET bromodomain inhibitors. The companyâs lead program is aimed at the treatment of patients with BRD4-NUT midline...
Researchers at Dana-Farber and the Baylor College of Medicine have shown that Tensha's bromodomain inhibitors could prevent sperm production and be developed as a male contraceptive. The biotech, whic...
Matching PubMed Articles